Here’s Why Madison Large Cap Fund Sold Elevance Health (ELV) in Q3
Madison Investments, an investment advisor, released its “Madison Large Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 3,998,603 | $1,292,028,537 | +25% | 2.35% |
| 2. | Harris Associates Natixis Global Asset Management | 3,189,624 | $1,030,631,439 | +40% | 1.65% |
| 3. | Brave Warrior Capital Glenn Greenberg | 1,834,002 | $592,602,726 | +66% | 13.76% |
| 4. | Eagle Capital Management Boykin Curry | 1,571,691 | $507,844,892 | -1% | 1.62% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,511,604 | $488,429,484 | +61% | 0.31% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $312.15 | 1,200 | $374,580.00 | 3,502 | 2025-08-19 | Filing | |
| $287.96 | 1,050 | $302,358.00 | 151,020 | 2025-07-18 | Filing | |
| $287.12 | 5,116 | $1,468,905.92 | 149,970 | 2025-07-18 | Filing | |
| $286.07 | 2,334 | $667,687.38 | 144,854 | 2025-07-18 | Filing | |
| $384.36 | 1,300 | $499,668.00 | 4,714 | 2021-07-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $424.82 | 4,588 | $1,949,074.16 | 18,977 | 2025-04-24 | Filing | |
| $415.13 | 443 | $183,902.59 | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | $1,388,635.20 | 10,116 | 2025-03-05 | Filing | |
| $432.14 | 7,417 | $3,205,182.38 | 8,423 | 2024-10-18 | Filing | |
| $531.52 | 753 | $400,234.56 | 8,744 | 2024-08-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,998,645 | $7,431,322,172 | 0.11% | |
| 2. | 20,533,269 | $6,634,710,108 | 0.12% | |
| 3. | 10,346,169 | $3,343,054,127 | 0.12% | |
| 4. | 6,621,297 | $2,139,473,488 | 0.37% | |
| 5. | 5,768,918 | $1,864,052,784 | 2.29% |
News See All
What Makes Elevance Health (ELV) an Investment Choice?
Pelican Bay Capital Management, an investment management company, released its third-quarter 2025 investor letter. A copy of the same can be downloaded here.
12 Most Undervalued Long-Term Stocks to Buy Right Now
On October 23, Gene Goldman, CIO at Cetera, joined CNBC television to discuss the market valuations and the sectors he thinks are undervalued.
Elevance Health (ELV) Announces Fiscal Q3 2025 Results
Elevance Health, Inc. (NYSE:ELV) is one of the best long term low volatility stocks to buy right now. Elevance Health, Inc.
14 Best Long Term Low Volatility Stocks to Buy Right Now
Mike Wilson, Morgan Stanley CIO and chief U.S.
Cantor Fitzgerald Reaffirms Its Overweight rating and $400 Price Target on Elevance Health, Inc. (ELV)
As 2026 Marketplace rates were set, Cantor Fitzgerald reaffirmed its Overweight rating and $400 price target, drawing attention to Elevance Health, Inc. (NYSE:ELV) on September 16, 2025.
20 NYSE Stocks with the Lowest P/E Ratios
The S&P 500 has risen almost 13% so far this year and recorded 25 record closes in the last three months, as U.S. markets hovered close to record highs on September 25, 2025, according to Reuters.
Here's What Affected Elevance (ELV) in Q2
Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Elevance Health, Inc. (ELV) Reaffirms Full-Year 2025 Earnings Guidance
Elevance Health, Inc. (NYSE:ELV) announced on September 4, 2025, that it expects to reaffirm its full-year 2025 earnings guidance during upcoming investor meetings.
Elevance Health Reduces Medicare Footprint, Exits Standalone Part D Plans for Profitability
Elevance Health Inc. (NYSE:ELV) is one of the best inexpensive stocks to buy according to hedge funds.